default author photo

Catherine Diefenbach

New York University (NYU) - Laura and Isaac Perlmutter Cancer Center

20 Cooper Square 3rd Floor

New York, NY 10003-711

United States

  • New York University (NYU) - Laura and Isaac Perlmutter Cancer Center

SCHOLARLY PAPERS

1

DOWNLOADS

73

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Safety and Efficacy of Polatuzumab Vedotin + Obinutuzumab for Relapsed/Refractory NHL: A Phase 1b/2 Study

Number of pages: 29 Posted: 08 Mar 2021
Tycel Phillips, Mark Brunvand, Andy I. Chen, James Essell, Annalisa Chiappella, Catherine Diefenbach, Ji Cheng, David Ramies, Jamie Hirata, Franck Morschhauser and Ian W. Flinn
University of Michigan at Ann Arbor - University of Michigan Medical School, Oregon Health and Science University, Oregon Health and Science University, Oncology Hematology Care Inc., Città Della Salute e della Scienza, New York University (NYU) - Laura and Isaac Perlmutter Cancer Center, Roche, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, University Hospital of Lille and Sarah Cannon Research Institute/Tennessee Oncology, PLLC
Downloads 73 (852,604)

Abstract:

Loading...